RWE Expert and Economist Details Future Global Market Access and Pricing Trends
November 16, 2021
Economist Ulf Staginnus shared his thoughts on future trends for market access and drug pricing in a recent discussion with The Evidence Base.
“In this interview, Ulf Staginnus (Blueprint Medicines, MA, USA) discusses the impact of real-world evidence (RWE) on pricing and market access, alongside the needs of stakeholders. ” Read more here.
(Source: Ulf Staginnus, The Evidence Base, 11/5/21)